DK1455190T3 - Fremgangsmåde til bestemmelse af den hormonelle virkning af stoffer ved hjælp af vekselvirkningen mellem androgenreceptoren og Ewings sarkom protein - Google Patents

Fremgangsmåde til bestemmelse af den hormonelle virkning af stoffer ved hjælp af vekselvirkningen mellem androgenreceptoren og Ewings sarkom protein

Info

Publication number
DK1455190T3
DK1455190T3 DK04003422T DK04003422T DK1455190T3 DK 1455190 T3 DK1455190 T3 DK 1455190T3 DK 04003422 T DK04003422 T DK 04003422T DK 04003422 T DK04003422 T DK 04003422T DK 1455190 T3 DK1455190 T3 DK 1455190T3
Authority
DK
Denmark
Prior art keywords
ewp
substances
determining
ewing
interaction
Prior art date
Application number
DK04003422T
Other languages
English (en)
Inventor
Maik Dr Obendorf
Siegmund Dr Wolf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2003109280 external-priority patent/DE10309280A1/de
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1455190T3 publication Critical patent/DK1455190T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
DK04003422T 2003-03-04 2004-02-16 Fremgangsmåde til bestemmelse af den hormonelle virkning af stoffer ved hjælp af vekselvirkningen mellem androgenreceptoren og Ewings sarkom protein DK1455190T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2003109280 DE10309280A1 (de) 2003-03-04 2003-03-04 Verfahren zur Bestimmung des hormonellen Effekts von Substanzen
US46569203P 2003-04-25 2003-04-25

Publications (1)

Publication Number Publication Date
DK1455190T3 true DK1455190T3 (da) 2007-03-12

Family

ID=32826202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04003422T DK1455190T3 (da) 2003-03-04 2004-02-16 Fremgangsmåde til bestemmelse af den hormonelle virkning af stoffer ved hjælp af vekselvirkningen mellem androgenreceptoren og Ewings sarkom protein

Country Status (8)

Country Link
US (1) US7208283B2 (da)
EP (1) EP1455190B1 (da)
JP (1) JP3862703B2 (da)
AT (1) ATE343795T1 (da)
DE (1) DE502004001834D1 (da)
DK (1) DK1455190T3 (da)
ES (1) ES2276179T3 (da)
PT (1) PT1455190E (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042574A1 (en) * 2003-11-03 2005-05-12 Acadia Pharmaceuticals Inc. High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
CA2588646A1 (en) * 2004-11-19 2006-05-26 Acadia Pharmaceuticals Inc. Methods to identify ligands of hormone nuclear receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410245B1 (en) 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
DE10054639B4 (de) * 2000-11-03 2004-05-06 Jenapharm Gmbh & Co. Kg Verwendung von RanBPM als Co-Modulator von Steroidhormonrezeptoren
DE10121710A1 (de) * 2001-05-04 2002-11-14 Jenapharm Gmbh Verfahren zur Testung des hormonellen Effekts von Substanzen
US20030082511A1 (en) * 2001-09-25 2003-05-01 Brown Steven J. Identification of modulatory molecules using inducible promoters

Also Published As

Publication number Publication date
US20040197827A1 (en) 2004-10-07
JP3862703B2 (ja) 2006-12-27
US7208283B2 (en) 2007-04-24
EP1455190A1 (de) 2004-09-08
PT1455190E (pt) 2007-02-28
ES2276179T3 (es) 2007-06-16
EP1455190B1 (de) 2006-10-25
ATE343795T1 (de) 2006-11-15
DE502004001834D1 (de) 2006-12-07
JP2004271524A (ja) 2004-09-30

Similar Documents

Publication Publication Date Title
NO20072721L (no) Polypeptides that bind BR3 and uses thereof
NO20054351L (no) Monoklonalt antistoff og hybridom som produserer dette
FI20041323A0 (fi) Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi
DK1848326T3 (da) System, method and apparatus for measuring blood flow and blood volume
ATE437370T1 (de) Pharmakodynamische tests mit durchflusszytometrie
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
EA200800826A1 (ru) Способ и устройство для определения кровотока в кровеносном сосуде
DK1804836T3 (da) Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer
WO2006001931A3 (en) Prouroguanylin as therapeutic and diagnostic agents
EA201000734A1 (ru) Способ и аппарат для мониторинга пространственного образования фибринового сгустка
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
EP1873522A4 (en) METHOD FOR DETERMINING A HEMOGLOBIN DERIVATIVE AND REAGENT COMPOSITION, TEST KIT, ANALYSIS DEVICE AND ANALYSIS SYSTEM FOR USE IN THE PROCESS
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
CY1110076T1 (el) Μεθοδος για τον καθορισμο της δεκτικοτητας σε αναστολεις chk1
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
WO2007010110A3 (fr) Procede de detection des fpca utilisant un agent d'agregation des fpca et un agent de capture des agregats formes
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
FR2913600B1 (fr) Dispositif pour l'application cutanee de substances.
DK1455190T3 (da) Fremgangsmåde til bestemmelse af den hormonelle virkning af stoffer ved hjælp af vekselvirkningen mellem androgenreceptoren og Ewings sarkom protein
WO2003031941A3 (en) Detection and characterization of pyschoactives using parallel multi-site assays in neuronal tissue
EP1917532A4 (en) ANTI-D-DIMER MONOCLONAL ANTIBODY AS A DIAGNOSTIC AGENT FOR DETECTING D-DIMER, RETICULATED FIBRIN AND ITS DERIVATIVES CONTAINING D-DIMERS
WO2005050203A3 (en) The methods for screening using ctgf and trka receptor for the identification of compounds for use in treatment of fibrosis
DK1750572T3 (da) Fremgangsmåde til bestemmelse af sympatikustonus og apparat til måling heraf